Literature DB >> 15228823

Physicians' practice for prevention of venous thromboembolism in medical patients.

Abdullah A Abba1, Mohammed A Al Ghonaim, Ahmed M Rufai.   

Abstract

OBJECTIVE: To audit physicians' practice of providing prophylaxis for venous thromboembolism (VTE) in patients admitted to acute- care medical wards and to determine the consequences of lack of prophylaxis.
DESIGN: Case-control comparative study. PLACE AND DURATION OF STUDY: All patients admitted to medical service of Riyadh Medical Complex (RMC) who stayed longer than six days were studied between July 2001 and 2002. PATIENTS AND METHODS: Demographic data as well as risk factors for VTE were identified for all patients who were divided in two groups. Patients who received prophylaxis (group-A) and those who did not (group-B) were both followed up. Type of prophylaxis and any complications were documented. Duplex ultrasound of the lower limbs was done in all patients in both groups and the outcome for all patients were documented.
RESULTS: Two hundred and forty-nine (249) patients were studied. Ninety-eight (39.35%) patients (group-A) received prophylaxis for VTE, while 151 (60.65%) patients (group-B) did not receive prophylaxis. Twenty-five point eight percent (25.8%), 37.5%, and 50% of patients with 3, 4 and 5 risk factors respectively did not receive thromboprophylaxis. Duplex sonography did not reveal deep venous thrombosis (DVT) in any patient of the two groups in hospital and upto one month after discharge. There was no statistical difference in mortality between the two groups.
CONCLUSION: Physicians' practice showed low threshold for providing VTE prophylaxis for medical patients. This was not translated to higher incidence of VTE or higher hospital mortality.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15228823     DOI: 04.2004/JCPSP.142145

Source DB:  PubMed          Journal:  J Coll Physicians Surg Pak        ISSN: 1022-386X            Impact factor:   0.711


  7 in total

1.  The AVAIL ME study: a multinational survey of VTE risk and prophylaxis.

Authors:  Ali T Taher; Joseph Aoun; Pascale Salameh
Journal:  J Thromb Thrombolysis       Date:  2011-01       Impact factor: 2.300

2.  Pattern of Venous Thrombosis in Cancer Patients: Frequency and Survival Effect; Single Center Experience.

Authors:  Amrallah A Mohammed; Abdullah S Al-Zahrani; Mian U Farooq; Hafez M Ghanem; Lobna A Abdelaziz; Hani M El-Khatib
Journal:  Indian J Hematol Blood Transfus       Date:  2015-01-23       Impact factor: 0.900

3.  Underutilization of venous thromboemoblism prophylaxis in medical patients in a tertiary care center.

Authors:  Ramy Masroujeh; Wael Shamseddeen; Hussain Isma'eel; Zaher K Otrock; Ismail M Khalil; Ali Taher
Journal:  J Thromb Thrombolysis       Date:  2007-08-15       Impact factor: 2.300

4.  Upstream investment in health care: national and regional perspectives.

Authors:  Mohamed Khalil; Hesham M Nadrah; Omer A Al-Yahia; Abdulla Al-Segul
Journal:  J Family Community Med       Date:  2005-01

5.  Antithrombotic prophylaxis in the middle East.

Authors:  Samir Arnaout; Hanady R Samaha; Julien Succar; Imad Bou-Akl; Khaled M Musallam; Ali T Taher
Journal:  Mediterr J Hematol Infect Dis       Date:  2011-05-24       Impact factor: 2.576

6.  Venous thromboprophylaxis in UK medical inpatients.

Authors:  S T Rashid; M R Thursz; N A Razvi; R Voller; T Orchard; S T Rashid; A A Shlebak
Journal:  J R Soc Med       Date:  2005-11       Impact factor: 18.000

7.  A cross-sectional, multicenter, observational study to assess the prophylaxis of venous thromboembolism in Lebanese and Jordanian hospitals.

Authors:  Imad Hajj; Mahmoud Al-Masri; Kaldoun Bashaireh; Mohammed Bani Hani; Shadi Hamouri; Joe Khouzami; Nisrine Sabra; Chahine Fadel
Journal:  Thromb J       Date:  2021-02-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.